title: CAR T-cell therapies: formulation-product-proposition framework for commercialisation.
authors.affiliation: Asklepian Consulting, International House, 24 Holborn Viaduct, London EC1A 2BN, United Kingdom. Electronic address: nmalik@asklepianconsulting.com.
authors.forename: Nafees N
authors.initials: NN
authors.lastname: Malik
authors.affiliation: Cell and Gene Therapy Catapult, 12th Floor Tower Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, United Kingdom.
authors.forename: Matthew B
authors.initials: MB
authors.lastname: Durdy
mesh_terms: D004339:Drug Compounding; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000191:economics / Q000639:trends*; D011946:Receptors, Antigen / Q000737:chemistry / Q000627:therapeutic use*; D013601:T-Lymphocytes; D018581:Technology Transfer
chemical_list: D011946:Receptors, Antigen